What is the appropriate injection depth for the levator labii superioris alaeque nasi (LLSAN) muscle when using Botox (onabotulinum toxin A)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 9, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Injection Depth for LLSAN with Botox

For levator labii superioris alaeque nasi (LLSAN) injections with Botox, inject superficially into the dermis or superficial muscle layer at approximately 2-3mm depth, avoiding deep intramuscular injection to prevent complications and maintain natural facial expression.

Anatomical Considerations

The LLSAN is a superficial facial muscle that requires precise, shallow injection technique. Based on recent anatomical studies and clinical experience:

  • Target depth: Superficial dermal to superficial muscle layer (2-3mm)
  • Injection approach: Perpendicular to skin initially, then advance at slight angle
  • Volume per site: 2 units per injection point is effective 1

Technical Approach

The injection technique should follow these principles:

Preparation and Localization:

  • Identify the LLSAN anatomically along the lateral aspect of the nose, extending from the nasal ala to the medial infraorbital region 2, 3
  • Mark injection sites before treatment
  • Consider using local anesthesia (EMLA cream) for patient comfort

Injection Technique:

  • Use a small-gauge needle (25-27G recommended based on similar facial muscle protocols)
  • Insert perpendicular to skin surface initially
  • Advance to superficial muscle layer (2-3mm depth)
  • Inject slowly with controlled pressure
  • Treat the entire target area including 1-2mm of surrounding tissue 2

Dosing Parameters

Standard dosing for LLSAN:

  • 2 units per injection site has demonstrated substantial aesthetic improvement 1
  • 4-6 units total when treating bilaterally for gummy smile correction 4
  • Effects typically visible within 2 days, with peak effect at 2 weeks 4

Critical Safety Points

Avoid these common pitfalls:

  • Do NOT inject deeply - Deep intramuscular injection increases risk of unwanted diffusion to adjacent muscles
  • Avoid injection near the nose tip - Risk of compromising nasal function
  • Do not inject near vascular areas - The LLSAN region has significant vascularity
  • Preserve natural expression - Superficial injection maintains facial harmony while achieving desired effect 1

Clinical Context

The LLSAN serves as a transitional muscle connecting nasal and perinasal muscles, making injection depth particularly important 5. Superficial injection:

  • Targets the muscle effectively without excessive diffusion
  • Preserves natural facial dynamics
  • Minimizes risk of functional deficits
  • Allows for predictable, reproducible results

Contraindications for superficial injection sites:

  • Active infection or inflammation at injection site
  • Compromised skin integrity
  • Areas with previous surgical scarring that may alter anatomy

Expected Outcomes

With proper superficial injection technique:

  • Onset of effect: 2 days 1
  • Peak effect: 2 weeks 4
  • Duration: Average 3-4 months (typical for facial Botox applications)
  • Patient satisfaction: Very high when technique is precise 6

The key to successful LLSAN injection is maintaining superficial depth while ensuring adequate coverage of the target muscle, which differs from deeper intramuscular injections used for other facial regions.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.